UTI - Healthcare Fund vs Nippon India Taiwan Equity Fund
UTI - Healthcare Fund (Direct) and Nippon India Taiwan Equity Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Sectoral/ Thematic schemes — see the best sectoral & thematic mutual funds for the full ranking.
Head to head
NAVs as of 31 Aug 2026
Growth of ₹100 (rebased over the selected window)
Common period 14 Dec 2021 – 31 Aug 2026, limited by Nippon India Taiwan Equity Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | UTI - Healthcare Fund | Nippon India Taiwan Equity Fund | Nifty 500 |
|---|---|---|---|
| 14 Dec 2021 | ₹100.00 | ₹100.00 | ₹100.00 |
| 06 May 2022 | ₹91.19 | ₹81.99 | ₹94.03 |
| 27 Sep 2022 | ₹90.14 | ₹67.29 | ₹97.90 |
| 17 Feb 2023 | ₹90.68 | ₹77.43 | ₹99.74 |
| 11 Jul 2023 | ₹104.19 | ₹93.50 | ₹110.67 |
| 01 Dec 2023 | ₹124.66 | ₹97.24 | ₹120.42 |
| 23 Apr 2024 | ₹138.74 | ₹103.74 | ₹137.29 |
| 13 Sep 2024 | ₹182.54 | ₹116.40 | ₹159.06 |
| 03 Feb 2025 | ₹171.55 | ₹119.79 | ₹142.27 |
| 27 Jun 2025 | ₹180.03 | ₹140.43 | ₹157.01 |
| 17 Nov 2025 | ₹185.33 | ₹181.18 | ₹159.24 |
| 10 Apr 2026 | ₹179.50 | ₹307.82 | ₹148.55 |
| 31 Aug 2026 | ₹221.60 | ₹382.26 | ₹156.10 |
| Metric | UTI · Direct NAV ₹392.74 Very High risk ★★★★☆ | Nippon India · Direct NAV ₹37.30 Very High risk ★★★★☆ | Category median Sectoral/ Thematic · 254 funds |
|---|---|---|---|
| +20.48% | +128.55%Best in row | +10.15% | |
| +25.23% | +59.31%Best in row | +16.43% | |
| +16.40% | — | +13.78% | |
| +15.05% | — | +14.94% | |
| +16.69% | +32.92%Best in row | +13.95% | |
| +22.87% | +57.20%Best in row | — | |
| +14.88% | +35.07%Best in row | +17.57% | |
| +13.87% | — | +16.31% | |
| +13.73% | — | +16.00% | |
| Risk | |||
| 13.42%Best in row | 35.82% | 15.53% | |
| 1.40 | 1.47Best in row | 0.56 | |
| 1.99 | 2.18Best in row | 0.76 | |
| -27.10%Best in row | -44.77% | -23.13% | |
| Nifty 500 | — | — | |
| +13.20% | — | +4.89% | |
| 0.76 | — | 0.96 | |
| 120.4% | — | 108.6% | |
| 55.7% | — | 91.0% | |
| 1.28% | 1.12%Best in row | 1.14% | |
| ₹1,181Cr | ₹1,110Cr | ₹1,134Cr | |
| Up to 1.00% | 1.00% | — | |
| ₹500 | ₹100 | — | |
| ₹5.00K | ₹500 | — | |
| 45% | 86% | 47% | |
| Kamal Gada | Kinjal Desai | — | |
| 02 Jan 2013 | 14 Dec 2021 | — | |
| 44 | — | — | |
| 42.6% | — | — | |
| 2.9% | 11.9% | — | |
1 row carries the same value for every fund — show
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — UTI - Healthcare Fund or Nippon India Taiwan Equity Fund?
Over the last 3 years, Nippon India Taiwan Equity Fund returned +59.31% CAGR against UTI - Healthcare Fund's +25.23%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — UTI - Healthcare Fund or Nippon India Taiwan Equity Fund?
Nippon India Taiwan Equity Fund has the lower expense ratio: UTI - Healthcare Fund charges 1.28% a year against Nippon India Taiwan Equity Fund's 1.12%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — UTI - Healthcare Fund or Nippon India Taiwan Equity Fund?
Nippon India Taiwan Equity Fund has shown higher volatility (+35.82% annualized vs UTI - Healthcare Fund's +13.42%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: UTI - Healthcare Fund -15.88% vs Nippon India Taiwan Equity Fund -37.58%.
Which fund manages more money — UTI - Healthcare Fund or Nippon India Taiwan Equity Fund?
UTI - Healthcare Fund is the larger fund: UTI - Healthcare Fund manages ₹1,181Cr against Nippon India Taiwan Equity Fund's ₹1,110Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are UTI - Healthcare Fund and Nippon India Taiwan Equity Fund in the same category?
Yes — both are Sectoral/ Thematic schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.